FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stuart Jon Spechler

Research Profile

Disorders

Procedures

Anatomy

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Edaire Cheng; Xiaofang Huo; Stuart Jon Spechler; David H Wang; Chunhua Yu; Qiuyang Zhang; Xi Zhang; Rhonda F Souza
Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.
Chunhua Yu; Hui Ying Zhang; Qiuyang Zhang; Xi Zhang; Jack L Arbiser; Edaire Cheng; Xiaofang Huo; Stuart Jon Spechler; David H Wang; Rhonda F Souza
Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells.
Stuart Jon Spechler
Buried (but not dead) Barrett's metaplasia: tales from the crypts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stuart Jon Spechler (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Edaire Cheng; Xiaofang Huo; Stuart Jon Spechler; David H Wang; Chunhua Yu; Qiuyang Zhang; Xi Zhang; Rhonda F Souza
Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.
Gut 2013;62(6):824-32.
2012: Chunhua Yu; Hui Ying Zhang; Qiuyang Zhang; Xi Zhang; Jack L Arbiser; Edaire Cheng; Xiaofang Huo; Stuart Jon Spechler; David H Wang; Rhonda F Souza
Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells.
American journal of physiology. Gastrointestinal and liver physiology 2012;303(5):G561-9.
2012: Stuart Jon Spechler
Buried (but not dead) Barrett's metaplasia: tales from the crypts.
Gastrointestinal endoscopy 2012;76(1):41-3.
2012: Kerry Brandt Dunbar; Stuart Jon Spechler
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.
The American journal of gastroenterology 2012;107(6):850-62; quiz 863.
2012: Bingru Xie; David H Wang; Stuart Jon Spechler
Sorafenib for treatment of hepatocellular carcinoma: a systematic review.
Digestive diseases and sciences 2012;57(5):1122-9.
2011: Nathan A Gray; Robert D Odze; Stuart Jon Spechler
Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review.
The American journal of gastroenterology 2011;106(11):1899-908; quiz 1909.
2011: Linda A Feagins; Stefan D Holubar; Sunanda V Kane; Stuart Jon Spechler
Current strategies in the management of intra-abdominal abscesses in Crohn's disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(10):842-50.
2011: Linda A Feagins; William V Harford; Raquel E Davila; Fatema S Uddin; Stuart Jon Spechler
The rate of post-polypectomy bleeding for patients on uninterrupted clopidogrel therapy during elective colonoscopy is acceptably low.
Digestive diseases and sciences 2011;56(9):2631-8.
2011: Kenneth R McQuaid; R Souza; M B Fennerty; L Laine; Stuart Jon Spechler
Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia.
Alimentary pharmacology & therapeutics 2011;34(2):146-65.
2011: Stuart Jon Spechler
Barrett's Esophagus without dysplasia: wait or ablate?
Digestive diseases and sciences 2011;56(7):1926-8.
2011: Stuart Jon Spechler
Pneumatic dilation and laparoscopic Heller's myotomy equally effective for achalasia.
The New England journal of medicine 2011;364(19):1868-70.
2011: Stuart Jon Spechler
Barrett's esophagus: Clinical issues.
Gastrointestinal endoscopy clinics of North America 2011;21(1):1-7.
2010: Linda A Feagins; Stuart Jon Spechler
Biologic agent use varies inversely with age at diagnosis in Crohn's disease.
Digestive diseases and sciences 2010;55(11):3164-70.
2010: John William Jacobs; Stuart Jon Spechler
A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis.
Digestive diseases and sciences 2010;55(6):1512-5.
2010: Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.
Gastroenterology 2010;138(3):854-69.
2009: Hui Ying Zhang; Kathy Hormi-Carver; Xi Zhang; Stuart Jon Spechler; Rhonda F Souza
In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks.
Cancer research 2009;69(23):9083-9.
2009: Stuart Jon Spechler
Surgery for gastroesophageal reflux disease: esophageal impedance to progress?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(12):1264-5.
2009: Ramalinga R Kedika; Rhonda F Souza; Stuart Jon Spechler
Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.
Digestive diseases and sciences 2009;54(11):2312-7.
2009: Rhonda F Souza; Xiaofang Huo; Vivek Mittal; Christopher M Schuler; Susanne W Carmack; Hui Ying Zhang; Xi Zhang; Chunhua Yu; Kathy Hormi-Carver; Robert M Genta; Stuart Jon Spechler
Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury.
Gastroenterology 2009;137(5):1776-84.
2009: Shehzad Nawaz Merwat; Stuart Jon Spechler
Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis?
The American journal of gastroenterology 2009;104(8):1897-902.
2009: Stuart Jon Spechler; Raquel Davila
Endoscopic therapy in Barrett's esophagus: when and how?
Surgical oncology clinics of North America 2009;18(3):509-21.
2009: Stuart Jon Spechler; P N Barker; D G Silberg
Clinical trial: intragastric acid control in patients who have Barrett's oesophagus--comparison of once- and twice-daily regimens of esomeprazole and lansoprazole.
Alimentary pharmacology & therapeutics 2009;30(2):138-45.
2009: Linda A Feagins; Vincent Chan; Stuart Jon Spechler
A case of duodenal Entamoeba histolytica.
Gastrointestinal endoscopy 2009;69(6):1184-6.
2009: Linda A Feagins; Rhonda F Souza; Stuart Jon Spechler
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.
Nature reviews. Gastroenterology & hepatology 2009;6(5):297-305.
2009: Hui Ying Zhang; Stuart Jon Spechler; Rhonda F Souza
Esophageal adenocarcinoma arising in Barrett esophagus.
Cancer letters 2009;275(2):170-7.
2008: Hui Ying Zhang; Xi Zhang; Xi Chen; Deena Thomas; Kathy Hormi-Carver; Frederick Elder; Stuart Jon Spechler; Rhonda F Souza
Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus.
American journal of physiology. Gastrointestinal and liver physiology 2008;295(3):G470-8.
2008: Stuart Jon Spechler; Rhonda F Souza
Biomarkers and photodynamic therapy for Barrett's esophagus: time to FISH or cut bait?
Gastroenterology 2008;135(2):354-7.
2008: Rhonda F Souza; Kumar Krishnan; Stuart Jon Spechler
Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
American journal of physiology. Gastrointestinal and liver physiology 2008;295(2):G211-8.
2008: Stuart Jon Spechler; Rhonda F Souza
Stem cells in Barrett's esophagus: HALOs or horns?
Gastrointestinal endoscopy 2008;68(1):41-3.
2008: Linda A Feagins; Hui Ying Zhang; Xi Zhang; Kathy Hormi-Carver; Tojo Thomas; Lance S Terada; Stuart Jon Spechler; Rhonda F Souza
Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines.
American journal of physiology. Gastrointestinal and liver physiology 2008;294(2):G411-7.
2008: George A Sarosi; G Brown; Kshama Jaiswal; Linda A Feagins; E Lee; T W Crook; Rhonda F Souza; Y S Zou; J W Shay; Stuart Jon Spechler
Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2008;21(1):43-50.
2008: Andrew Fenves; C Richard Boland; Rita Lepe; Paulino Rivera-Torres; Stuart Jon Spechler
Fatal hyperammonemic encephalopathy after gastric bypass surgery.
The American journal of medicine 2008;121(1):e1-2.
2008: Seema S Aceves; Glenn T Furuta; Stuart Jon Spechler
Integrated approach to treatment of children and adults with eosinophilic esophagitis.
Gastrointestinal endoscopy clinics of North America 2008;18(1):195-217; xi.
2007: Hui-Ying Zhang; Xi Zhang; Kathy Hormi-Carver; Linda A Feagins; Stuart Jon Spechler; Rhonda F Souza
In non-neoplastic Barrett's epithelial cells, acid exerts early antiproliferative effects through activation of the Chk2 pathway.
Cancer research 2007;67(18):8580-7.
2007: Stuart Jon Spechler
Screening and surveillance for Barrett's esophagus-an unresolved dilemma.
Nature clinical practice. Gastroenterology & hepatology 2007;4(9):470-1.
2007: Edgardo Diaz-cervantes; Antonio de la Torre Bravo; Stuart Jon Spechler; Ernesto Torres-Durazo; Sergio Sobrino Cossio; Olimpia Martínez-Carrillo; Javier Gamboa-Robles
Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium: results of a pilot study.
The American journal of gastroenterology 2007;102(8):1640-5.
2007: Rhonda F Souza; Tisha Lunsford; Ruben D Ramirez; Xi Zhang; Edward L Lee; Yuenan Shen; Charles Owen; Jerry W Shay; Carmela Morales; Stuart Jon Spechler
GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus.
American journal of physiology. Gastrointestinal and liver physiology 2007;293(1):G19-24.
2007: Stuart Jon Spechler; Robert Genta; Rhonda F Souza
Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis.
The American journal of gastroenterology 2007;102(6):1301-6.
2007: Jin Si; Xiaoying Fu; Jose Behar; Jack R Wands; David G Beer; Rhonda F Souza; Stuart Jon Spechler; David J. Lambeth; Weibiao Cao
NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-kappaB in Barrett's esophageal adenocarcinoma cells.
The Journal of biological chemistry 2007;282(22):16244-55.
2007: Irvin M Modlin; Peter Malfertheiner; Richard H Hunt; David Armstrong; Gerald Holtmann; Eamon M Quigley; Stuart Jon Spechler
GERD evaluation: time for a new paradigm?
Journal of clinical gastroenterology 2007;41(3):237-41.
2007: Kshama Jaiswal; Carmela P Morales; Linda A Feagins; Kenia Gandia; Xi Zhang; H-Y Zhang; Kathy Hormi-Carver; Yuenan Shen; Frederick F Elder; Ruben D Ramirez; George A Sarosi; Stuart Jon Spechler; Rhonda F Souza
Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T).
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2007;20(3):256-64.
2007: Linda A Feagins; Hui-Ying Zhang; Kathy Hormi-Carver; Mizael H Quinones; Deena Thomas; Xi Zhang; Lance S Terada; Stuart Jon Spechler; Ruben D Ramirez; Rhonda F Souza
Acid has antiproliferative effects in nonneoplastic Barrett's epithelial cells.
The American journal of gastroenterology 2007;102(1):10-20.
2007: Ali Siddiqui; Stuart Jon Spechler; Sergio Huerta
Surgical bypass versus endoscopic stenting for malignant gastroduodenal obstruction: a decision analysis.
Digestive diseases and sciences 2007;52(1):276-81.
2007: Kathy Hormi-Carver; Linda A Feagins; Stuart Jon Spechler; Rhonda F Souza
All trans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett's cells.
American journal of physiology. Gastrointestinal and liver physiology 2007;292(1):G18-27.
2006: Stuart Jon Spechler; Prateek Sharma; Barry Traxler; Douglas Levine; Gary W Falk
Gastric and esophageal pH in patients with Barrett's esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial.
The American journal of gastroenterology 2006;101(9):1964-71.
2006: Stuart Jon Spechler
Thermal ablation of Barrett's esophagus: a heated debate.
The American journal of gastroenterology 2006;101(8):1770-2.
2006: Irving Waxman; Gottumukkala S Raju; Jonathan Critchlow; Donald A Antonioli; Stuart Jon Spechler
High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series.
The American journal of gastroenterology 2006;101(8):1773-9.
2006: Valeska Balderas; Stuart Jon Spechler
Upper gastrointestinal bleeding in a patient with AIDS.
Nature clinical practice. Gastroenterology & hepatology 2006;3(6):349-53; quiz following 353.
2006: Linda A Feagins; Nathan Susnow; Hui Ying Zhang; Stephanie Pearson; Charles Owen; William F Schmalstieg; Lance S Terada; Stuart Jon Spechler; Ruben D Ramirez; Rhonda F Souza
Gain of allelic gene expression for IGF-II occurs frequently in Barrett's esophagus.
American journal of physiology. Gastrointestinal and liver physiology 2006;290(5):G871-5.
2006: Stuart Jon Spechler
Laryngopharyngeal reflux: a cause of faulty phonation or a faulted, phony diagnosis?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(4):431-2.
2006: Kshama Jaiswal; Christie Lopez-Guzman; Rhonda F Souza; Stuart Jon Spechler; George A Sarosi
Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.
American journal of physiology. Gastrointestinal and liver physiology 2006;290(2):G335-42.
2005: George A Sarosi; Kshama Jaiswal; Emily Herndon; Christie Lopez-Guzman; Stuart Jon Spechler; Rhonda F Souza
Acid increases MAPK-mediated proliferation in Barrett's esophageal adenocarcinoma cells via intracellular acidification through a Cl-/HCO3- exchanger.
American journal of physiology. Gastrointestinal and liver physiology 2005;289(6):G991-7.
2005: Rhonda F Souza; Stuart Jon Spechler
Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach.
CA: a cancer journal for clinicians 2005;55(6):334-51.
2005: Stuart Jon Spechler
Barrett's esophagus: a molecular perspective.
Current gastroenterology reports 2005;7(3):177-81.
2005: Thomas Tran; Stuart Jon Spechler; Peter Richardson; Hashem B El-Serag
Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study.
The American journal of gastroenterology 2005;100(5):1002-8.
2005: Stuart Jon Spechler
Dysplasia in Barrett's esophagus: limitations of current management strategies.
The American journal of gastroenterology 2005;100(4):927-35.
2005: Rhonda F Souza; Kenneth Shewmake; Yuenan Shen; Ruben D Ramirez; Jeff S Bullock; Christa L Hladik; Edward L Lee; Lance S Terada; Stuart Jon Spechler
Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
The American journal of gastroenterology 2005;100(3):551-9.
2005: Irvin M Modlin; Guido Adler; Kathey Alexander; Rudolf Arnold; David A Brenner; Enrico Corazziari; Martin H Floch; Ronald E LaPorte; Walter L Peterson; Eamonn M Quigley; Michael D Shapiro; Stuart Jon Spechler; Robin C Spiller; G N J Tytgat; Wolfram Wiegers
Information assimilation and distribution challenges and goals for real and virtual journals.
Journal of clinical gastroenterology 2005;39(3):181-8.
2005: Stuart Jon Spechler
Risk of community-acquired pneumonia after acid-suppressive drugs.
Nature clinical practice. Gastroenterology & hepatology 2005;2(2):72-3.
2004: Stuart Jon Spechler
Should patients with GERD be screened once at least for Barrett's epithelium? A balancing view: To screen or not to screen: scoping out the issues.
The American journal of gastroenterology 2004;99(12):2295-6.
2004: Joseph R Pisegna; Gerald Holtmann; Colin W Howden; P H Katelaris; Prateek Sharma; Stuart Jon Spechler; George Triadafilopoulos; G N J Tytgat
Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 2004;20 Suppl 9():47-56.
2004: Stuart Jon Spechler
What is the long-term effect of high-dose versus standard-dose omeprazole in patients with dyspepsia?
Nature clinical practice. Gastroenterology & hepatology 2004;1(1):12-3.
2004: Stuart Jon Spechler
Review article: what I do now to manage adenocarcinoma risk, and what I may be doing in 10 years' time.
Alimentary pharmacology & therapeutics 2004;20 Suppl 5():105-10.
2004: Rhonda F Souza; Kenneth Shewmake; Stephanie Pearson; George A Sarosi; Linda A Feagins; Ruben D Ramirez; Lance S Terada; Stuart Jon Spechler
Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells.
American journal of physiology. Gastrointestinal and liver physiology 2004;287(4):G743-8.
2004: Christopher D Lao; Patricia Backoff; Lawrence I Shotland; Deborah McCarty; Tracy Eaton; Frank G Ondrey; Jaye L Viner; Stuart Jon Spechler; Ernest T Hawk; Dean E Brenner
Irreversible ototoxicity associated with difluoromethylornithine.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(7):1250-2.
2004: Miguel R Arguedas; Gustavo R Heudebert; Joshua C Klapow; Robert M Centor; Mohamad A Eloubeidi; C Mel Wilcox; Stuart Jon Spechler
Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection.
The American journal of gastroenterology 2004;99(6):1023-8.
2004: Stuart Jon Spechler
The management of patients who have "failed" antireflux surgery.
The American journal of gastroenterology 2004;99(3):552-61.
2004: Stuart Jon Spechler
Intestinal metaplasia at the gastroesophageal junction.
Gastroenterology 2004;126(2):567-75.
2004: Stuart Jon Spechler
Are we underestimating acid reflux?
Gut 2004;53(2):162-3.
2003: Stuart Jon Spechler
Clinical manifestations and esophageal complications of GERD.
The American journal of the medical sciences 2003;326(5):279-84.
2003: Rhonda F Souza; Stuart Jon Spechler
Barrett's esophagus: chemoprevention.
Gastrointestinal endoscopy clinics of North America 2003;13(3):419-32.
2003: Reza Shaker; Donald Castell; Philip Schoenfeld; Stuart Jon Spechler
Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association.
The American journal of gastroenterology 2003;98(7):1487-93.
2003: Stuart Jon Spechler
The natural history of dysplasia and cancer in esophagitis and Barrett esophagus.
Journal of clinical gastroenterology 2003;36(5 Suppl):S2-5; discussion S26-8.
2003: Stuart Jon Spechler
Managing Barrett's oesophagus.
BMJ (Clinical research ed.) 2003;326(7395):892-4.
2003: Carmela P Morales; Stuart Jon Spechler
Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers.
The American journal of gastroenterology 2003;98(4):759-62.
2003: Stuart Jon Spechler
Medical or invasive therapy for GERD: an acidulous analysis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2003;1(2):81-8.
2003: Stuart Jon Spechler
Therapeutic approaches to reflux disease: newer approaches and strategies to columnar-lined esophagus.
Journal of gastroenterology 2003;38 Suppl 15():20-4.
2003: Carmela P Morales; Kenia Gandia; Ruben D Ramirez; Woodring E Wright; Jerry W Shay; Stuart Jon Spechler
Characterisation of telomerase immortalised normal human oesophageal squamous cells.
Gut 2003;52(3):327-33.
2003: Stuart Jon Spechler
A 59-year-old woman with gastroesophageal reflux disease and Barrett esophagus.
JAMA : the journal of the American Medical Association 2003;289(4):466-75.
2003: Stuart Jon Spechler
Esophageal complications of gastroesophageal reflux disease: presentation, diagnosis, management, and outcomes.
Clinical cornerstone 2003;5(4):41-8; discussion 49-50.
2003: Steven F Moss; David Armstrong; Rudi Arnold; Peter Ferenci; Kwong Ming Fock; Gerald Holtmann; Denis M McCarthy; Joaquim P Moraes-Filho; Ernst Mutschler; Raymond Playford; Stuart Jon Spechler; Vincenzo Stanghellini; Irvin M Modlin
GERD 2003 -- a consensus on the way ahead.
Digestion 2003;67(3):111-7.
2002: Carmela P Morales; Rhonda F Souza; Stuart Jon Spechler
Hallmarks of cancer progression in Barrett's oesophagus.
Lancet 2002;360(9345):1587-9.
2002: Stuart Jon Spechler
Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy.
The Medical clinics of North America 2002;86(6):1423-45, vii.
2002: Stuart Jon Spechler
Carcinogenesis at the gastroesophageal junction: free radicals at the frontier.
Gastroenterology 2002;122(5):1518-20.
2002: Stuart Jon Spechler
Clinical practice. Barrett's Esophagus.
The New England journal of medicine 2002;346(11):836-42.
2002: Stuart Jon Spechler
Columnar-lined esophagus. Definitions.
Chest surgery clinics of North America 2002;12(1):1-13, vii.
2002: Rhonda F Souza; Kenneth Shewmake; Lance S Terada; Stuart Jon Spechler
Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus.
Gastroenterology 2002;122(2):299-307.
2002: Stuart Jon Spechler
Screening for Barrett's esophagus.
Reviews in gastroenterological disorders 2002;2 Suppl 2():S25-9.
2001: Stuart Jon Spechler
Screening and surveillance for complications related to gastroesophageal reflux disease.
The American journal of medicine 2001;111 Suppl 8A():130S-136S.
2001: Rhonda F Souza; Carmela P Morales; Stuart Jon Spechler
Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus.
Alimentary pharmacology & therapeutics 2001;15(8):1087-100.
2001: Stuart Jon Spechler; Donald Castell
Classification of oesophageal motility abnormalities.
Gut 2001;49(1):145-51.
2001: Stuart Jon Spechler
Acid suppression therapy for Barrett's esophagus.
The European journal of surgery. Supplement. : = Acta chirurgica. Supplement 2001;(586):78-81.
2000: Rhonda F Souza; Kenneth Shewmake; David G Beer; B Cryer; Stuart Jon Spechler
Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Cancer research 2000;60(20):5767-72.
2000: Stuart Jon Spechler
Barrett's oesophagus: diagnosis and management.
Baillière's best practice & research. Clinical gastroenterology 2000;14(5):857-79.
2000: Stuart Jon Spechler; L Fischbach; M Feldman
Clinical aspects of genetic variability in Helicobacter pylori.
JAMA : the journal of the American Medical Association 2000;283(10):1264-6.
2000: Stuart Jon Spechler
Medical treatment of Barrett's esophagus.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2000;4(2):119-21.
1999: Stuart Jon Spechler
AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus.
Gastroenterology 1999;117(1):233-54.
1999: Stuart Jon Spechler
American gastroenterological association medical position statement on treatment of patients with dysphagia caused by benign disorders of the distal esophagus.
Gastroenterology 1999;117(1):229-33.
1999: Stuart Jon Spechler
The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction.
Gastroenterology 1999;117(1):218-28.
1997: Stuart Jon Spechler
The columnar-lined esophagus. History, terminology, and clinical issues.
Gastroenterology clinics of North America 1997;26(3):455-66.